Treatment Of Sepsis With PCSK9 And LDLR Modulators
US-2026078378-A1 · Mar 19, 2026 · US
Damask Amy is listed as an inventor on 13 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Damask Amy |
| Total patents | 13 |
| First publication | Sep 4, 2018 |
| Latest publication | Mar 19, 2026 |
Publications ranked by popularity score, then publication date.
US-2026078378-A1 · Mar 19, 2026 · US
US-2025257406-A1 · Aug 14, 2025 · US
US-12378557-B2 · Aug 5, 2025 · US
US-12264366-B2 · Apr 1, 2025 · US
US-2024404627-A1 · Dec 5, 2024 · US
US-2023340598-A1 · Oct 26, 2023 · US
US-2023113866-A1 · Apr 13, 2023 · US
US-2022177982-A1 · Jun 9, 2022 · US
US-2022064652-A1 · Mar 3, 2022 · US
US-2021002724-A1 · Jan 7, 2021 · US
Latest publications not already listed above.
US-2020178741-A1 · Jun 11, 2020 · US
US-2019082912-A1 · Mar 21, 2019 · US
US-10066267-B2 · Sep 4, 2018 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Regeneron Pharma | 10 |
| Novartis Ag | 3 |
| Damask Amy | 1 |
| Lewitzky Steven | 1 |
| Rotte Michael | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12Q1/6883 | 11 |
| C12Q2600/156 | 11 |
| C07K2317/76 | 6 |
| A61K2039/505 | 6 |
| C12Q2600/118 | 6 |